Mowi ASA invites stakeholders to Q2 2026 results presentation on August 18, 2026, signaling upcoming financial disclosure for the world’s largest salmon farmer
Executive summary: Mowi ASA announced a presentation of its Q2 2026 financial results to be held on August 18, 2026, at 08:00 CET in Oslo, Norway. As the world’s largest producer of farmed salmon, Mowi’s quarterly results influence global seafood markets, feed demand, and investor sentiment in aquaculture.
Who is involved: Mowi ASA (OSE:MOWI), its investors, analysts, and the broader aquaculture and seafood industry.
Likely next: The presentation will disclose Q2 2026 financial performance, potentially including revenue, harvest volumes, operating margins, and outlook for the second half of 2026.
Mowi ASA has announced a public presentation of its second-quarter 2026 financial results scheduled for August 18, 2026, at 08:00 CET in Oslo. The event will be held at The Salmon, Strandpromenaden 11, and is intended to provide investors and analysts with updated performance metrics. This follows the company’s July 15 trading update, which outlined harvest volumes and market conditions for the period. As a dominant player in global aquaculture, Mowi’s Q2 results are closely watched for indicators of salmon pricing, feed costs, and regional production trends.
What's next — scenarios
Operational Efficiency & Margin Expansion (40%)
Higher EBITDA margins drive institutional buy-side interest in aquaculture stocks.
- Lower feed cost-to-revenue ratio
- Harvest volumes meeting or exceeding July 15 guidance
Supply-Side Volatility & Margin Compression (35%)
Increased input costs or biological challenges lead to immediate downward pressure on stock valuation.
- Unexpected spike in biological cost metrics
- Lower realized salmon prices compared to market benchmarks
Macro-Driven Market Stagnation (25%)
Strong company performance is offset by global demand weakness, keeping stock sideways.
- Flat revenue growth despite high harvest volumes
- Guidance revision downward for H2 2026 due to consumer demand
What to watch
- Q2 2026 Earnings Release: August 18, 2026
- Salmon spot price trends vs. Mowi realized price: August 2026
- Feed ingredient index updates: Next 30 days
Timeline
- — Mowi ASA (OSE:MOWI): Presentation of Q2 2026 results 18 August 2026 at 08:00 (CET) (GlobeNewswire)
- — Mowi ASA (OSE:MOWI): Q2 2026 Trading update (GlobeNewswire)
Analysis — what this means
Likely next events
- Mowi ASA Q2 2026 results presentation – August 18, 2026, 08:00 CET, Oslo
- Potential release of Q2 2026 harvest volume and pricing data – on or before August 18, 2026
Sectors affected
- Global aquaculture
- Salmon farming
- Fish feed production
- Seafood retail and distribution
Regulatory implications
- EU organic aquaculture standards may affect labeling and premium pricing if Mowi reports growth in certified segments
Historical parallels
- Mowi Q1 2023 results showed biomass challenges due to biological issues, leading to revised guidance – similar risks monitored in 2026
- Q2 2022 results benefited from strong salmon prices post-pandemic supply recovery – a comparative benchmark for 2026 performance
- Q2 2020 results were impacted by early pandemic logistics disruptions – a contrast to current stable supply chains
Key entities
Sources
- Mowi ASA (OSE:MOWI): Presentation of Q2 2026 results 18 August 2026 at 08:00 (CET) — GlobeNewswire
- Mowi ASA (OSE:MOWI): Q2 2026 Trading update — GlobeNewswire
Related cases
- AKVA group ASA declares a NOK 1.00 per share dividend payable after the ex-dividend date of 15 September 2026
- HaloMD joins ASA Innovator Supporter Program to strengthen IDR navigation under the No Surprises Act
- Sivers Semiconductors invites investors to its Q2 2026 earnings presentation, signaling an upcoming financial disclosure
- AKVA group ASA invites investors to Q2 2026 results presentation, signaling imminent financial disclosure
- DNO ASA sets date for Q2 2026 results release and invites investors to earnings call
- Hofseth BioCare’s peer‑reviewed ProGo study demonstrates GLP‑1‑like effects and increased lean muscle mass, strengthening its position in the functional protein market